
for Sustainable Health
VISSAN BioLabs
We are the small private laboratory of biopharmaceutical research located in Slovakia.
​
Deciphering the bioactive profile of secondary metabolites from natural products and exploring therapeutic usefulness of various TLR agonists and combined approaches is at the core of our permanent research interests associated with in-house pharmaceutical development.
​
Our proprietary microbial biosynthesis platform suffices to modeling of various new and safe therapeutic strategies based on specific TLR2, -3, -4, -7/8, and -9 agonists.
Compound
Mechanism of action/Modality
Indication
Development stage
09092022
Ischemic preconditioning through low-dose modulation of TLR hyporeactivity.
Tolerance to hypoxia-ischaemia
Recurrent stroke secondary prevention (after TIA).
Neuroprotection, modulating neuroinflammation
09092022
Increasing hippocampal neurogenesis, antidepressant-like effects and reversal of stress-induced anhedonia, improving cognitive ability
Post-stroke recovery.
Slowing down or halting neurodegeneration, boosting adult neurogenesis for neurodegeneration-related cognitive decline.
Treatment of anhedonia and depressive disorders
VM71224
Regulator of tumor immune microenvironment.
Th1 cytotoxic responses induction
Cancer immunotherapy
Discovery
Preclinical
Preclinical